An app to support people with Multiple Sclerosis
An Individualized-health eLibrary App for People With Multiple Sclerosis: Testing Feasibility and Effectiveness of a Brief Education Intervention
This study tests whether an app called SavvyHealth can help people with Multiple Sclerosis manage their health better over 21 days.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Illinois at Urbana-Champaign Academic / other |
| Locations | 1 site (Champaign, Illinois) |
| Trial ID | NCT05124600 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an individualized-health e-library app called SavvyHealth for individuals diagnosed with Multiple Sclerosis. Participants will use the app for a duration of 21 days, during which they will complete a survey before and after using the app to assess its impact on their health management. The study aims to determine how well the app supports users in managing their condition and improving their health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with Multiple Sclerosis and have at least one comorbidity.
Not a fit: Patients who do not have Multiple Sclerosis or are unwilling to use the app for the required duration may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could enhance the self-management and health outcomes of patients with Multiple Sclerosis.
How similar studies have performed: Other studies have shown promise in using mobile health applications for chronic disease management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosed with MS; * 18 years or older; * one comorbidity evaluated by a validated comorbidity questionnaire for people with MS; * willing to take a survey; * willing to use the app for 21 days; * willing to be assigned to either the intervention or control group. Exclusion Criteria: \-
Where this trial is running
Champaign, Illinois
- University of Illinois Urbana-Champaign — Champaign, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Chungyi Chiu — University of Illinois at Urbana-Champaign
- Study coordinator: Chungyi Chiu
- Email: chiucy@illinois.edu
- Phone: 217-244-6435
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.